Trinity Biotech Plc. reported the receipt of a formal notification from The Nasdaq Stock Market LLC that the Company has regained compliance with Listing Rule 5450(a)(1),...
Bruker Corporation announced the successful closing of its acquisition of Chemspeed Technologies AG. This acquisition, first announced in January 2024, marks another significant milestone in Bruker’s...
Inogen, Inc. announced that, effective March 4, 2024, the Compensation Committee of Inogen’s Board of Directors approved awards of restricted stock units as material inducement to...
Fijoya announced an $8.3M funding round led by the Venture-Creation fund of Team8. Employer-sponsored healthcare is a $1.5 trillion industry riddled with escalating costs, administrative overload,...
Clover Health announced Clay Thornton as the newly appointed Chief Financial Officer of its Medicare Advantage (MA) division. Thornton, with an impressive track record spanning over...
SurGenTec announced the first implantations and 510(k) clearance from the U.S. Food and Drug Administration (FDA) for its OsteoFlo HydroPutty Synthetic Bone Graft. OsteoFlo HydroPutty represents...
Johnson & Johnson announced it has successfully completed the acquisition of Ambrx Biopharma, Inc., in an all-cash merger transaction for a total equity value of approximately...
BIOBOT Surgical announced a significant milestone in their journey: the successful closure of their Series B funding round, securing an impressive S$24 MM (US$ 18 MM)....
Myomo, Inc. announced financial results for the three months and year ended December 31, 2023. Financial and operational highlights for the fourth quarter of 2023 include...
Rakuten Medical, Inc. announced the completion of a $119 million Series E preferred stock financing, including $45 million in new capital and the conversion of $74...
Evogene Ltd. announced its financial results for the fourth quarter and full-year period ending December 31, 2023. Ofer Haviv, Evogene’s President, and Chief Executive Officer, stated,...
Alafair Biosciences, Inc., announced business results and highlights for 2023. Alafair’s flagship product, VersaWrap®, is an FDA-cleared medical device implant (not tissue) comprising hyaluronic acid (HA)...
bioAffinity Technologies, Inc. announced it has entered into a securities purchase agreement with institutional investors for the purchase and sale of 1,600,000 shares of common stock...
PruittHealth Medical Supply announced its acquisition of Allied Health Resources (AHR). All Allied Health Resources technicians and customer service partners have been retained by PruittHealth Medical...
Sionna Therapeutics announced the closing of a $182 million Series C financing to support the clinical development of first-in-class small molecules designed to fully restore the...
Copyright © 2024 Medical Buyer